US EditionHugel launches botulinum toxin Letybo in Malaysia
MALAYSIA, AUG 11 – Hugel partnered with Venusys Medical to train 100 local professionals on botulinum toxin injection techniques at a major Malaysian medical aesthetics conference.
- On Aug. 10, 2025, Hugel Inc., chaired by Suk Cha, launched Letybo in Malaysia through Venusys Medical Sdn Bhd to expand its premium toxin presence.
- Founded in 2001, Hugel Inc. is a global leader in medical aesthetics with approvals in the US, China, and Europe, and presence in 70 countries through nine subsidiaries.
- During Aug. 6 to 7, Venusys Medical Sdn Bhd introduced Letybo at the AMSC conference, with a training session held at The Zenith Hotel Kuantan, attended by around 100 local professionals.
- A Hugel official said, `We will continue to offer customized training programs for local medical professionals in Malaysia through our strategic collaboration with Venusys Medical` to bolster industry development and market penetration.
- Drawing on its Malaysian partnership, Hugel leverages Venusys Medical Sdn Bhd’s distribution network across Malaysia and Singapore to expand Letybo’s regional outreach.
Insights by Ground AI
Does this summary seem wrong?
62 Articles
62 Articles
Coverage Details
Total News Sources62
Leaning Left7Leaning Right6Center25Last UpdatedBias Distribution66% Center
Bias Distribution
- 66% of the sources are Center
66% Center
L 18%
C 66%
R 16%
Factuality
To view factuality data please Upgrade to Premium
